What does Arno Therapeutics, Inc. do?

Arno Therapeutics, Inc. (ARNI) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is ARNI's market cap?

Arno Therapeutics, Inc. (ARNI) has a market capitalization of approximately $4,935, as of August 25, 2026, based on the most recent share price and shares outstanding.

Does ARNI pay a dividend?

No — Arno Therapeutics, Inc. (ARNI) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

Arno Therapeutics, Inc. (ARNI) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

ARNI

Arno Therapeutics, Inc.

OTC·Biotechnology · Healthcare

$0.00$0.00+0.00%

Market cap$4.94K·Market closed·Aug 25 8:00 PM UTC

Price Chart

$0.00+$0.00 (+0.00%)today

−97.78%CAGR −53.30%

Select date range

FromTo

Jun 11, 2008Aug 27, 2021 → Aug 27, 2026· 5.0 yrsAug 27, 2026

Key Metrics

ARNI does not currently pay a dividend.

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings Date—

Last Report Date—

Reported vs Estimate—

Earnings Surprise—

FinancialsFinancials Tab

Revenue$0.00

Net Income−$13.74M

Net Margin—

Operating Cash Flow−$7.62M

Capital Expenditures$0.00

Free Cash Flow−$7.62M

Return on Equity—

Return on Invested Capital−268.0%

Net Cash$2.12M

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for ARNI and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how ARNI's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for ARNI and 80,000+ other tickers.

About Arno Therapeutics, Inc.

Arno Therapeutics, Inc., headquartered in Flemington, New Jersey, operates as a biopharmaceutical enterprise focused on discovering and advancing treatments for cancer and other severe health conditions. The company's developmental portfolio includes several key compounds: Onapristone, a type 1 anti-progestin hormone blocker, is currently undergoing Phase I/II clinical trials. This therapeutic is being investigated for its efficacy in treating various solid tumors, such as breast and endometrial cancers in post-menopausal women, and advanced castration-resistant prostate cancer in men. AR-12…

CEO: David M. Tanen
Sector: Healthcare
Industry: Biotechnology
Exchange: OTC
Employees: 4
Website: www.arnothera.com

Peers

Peers Tab

PANC

Panacos Pharmaceuticals, Inc.

Cap

$5.4K

CALA

Calithera Biosciences, Inc.

Cap

$487.0

TLOG

TetraLogic Pharmaceuticals Corporation

Cap

$979.0

Latest News

News Tab

No recent news available.

Frequently Asked Questions About ARNI

What does Arno Therapeutics, Inc. do?: Arno Therapeutics, Inc. (ARNI) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is ARNI's market cap?: Arno Therapeutics, Inc. (ARNI) has a market capitalization of approximately $4,935, as of August 25, 2026, based on the most recent share price and shares outstanding.
Does ARNI pay a dividend?: No — Arno Therapeutics, Inc. (ARNI) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.
Is ARNI profitable?: Arno Therapeutics, Inc. (ARNI) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.